<VariationArchive VariationID="21452" VariationName="NM_006329.3(FBLN5):c.380-9061_873dup" VariationType="Duplication" Accession="VCV000021452" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2019-09-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="34304" VariationID="21452">
      <GeneList>
        <Gene Symbol="FBLN5" FullName="fibulin 5" GeneID="10516" HGNC_ID="HGNC:3602" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q32.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="91869411" stop="91947694" display_start="91869411" display_stop="91947694" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="92335754" stop="92414045" display_start="92335754" display_stop="92414045" Strand="-" />
          </Location>
          <OMIM>604580</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006329.3(FBLN5):c.380-9061_873dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q32.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="91881408" stop="91904133" display_start="91881408" display_stop="91904133" variantLength="22726" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="92347752" stop="92370477" display_start="92347752" display_stop="92370477" variantLength="22726" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008254.1" sequenceAccession="NG_008254" sequenceVersion="1" change="g.48570_71295dup">
            <Expression>NG_008254.1:g.48570_71295dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_364t1" sequenceAccession="LRG_364t1" change="c.380-9061_873dup">
            <Expression>LRG_364t1:c.380-9061_873dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_364" sequenceAccession="LRG_364" change="g.48570_71295dup">
            <Expression>LRG_364:g.48570_71295dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006329.3" sequenceAccession="NM_006329" sequenceVersion="3" change="c.380-9063_872dup22729">
            <Expression>NM_006329.3:c.380-9063_872dup22729</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604580.0002" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 12618961 to determine the location of this allele on current reference sequence.</Comment>
      <Comment DataSource="NCBI curation" Type="public">Duplication from intron 4 to exon 9 in gene FBLN5 comprising 22,729-nt.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006329.3(FBLN5):c.380-9061_873dup AND Cutis laxa, autosomal dominant 2" Accession="RCV000005810" Version="10">
        <ClassifiedConditionList TraitSetID="7875">
          <ClassifiedCondition DB="MedGen" ID="C3280794">Cutis laxa, autosomal dominant 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2019-09-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12618961</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7875" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16804" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cutis laxa, autosomal dominant 2</ElementValue>
                <XRef ID="MONDO:0013751" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ADCL2</ElementValue>
                <XRef Type="MIM" ID="614434" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">FBLN5-related cutis laxa is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder such as inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvar aortic stenosis is observed. Intrafamilial variability in age of onset is observed. Cardiorespiratory failure from complications of pulmonary emphysema (respiratory or cardiac insufficiency) is the most common cause of death.</Attribute>
                <XRef ID="NBK5201" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15802" />
                <XRef ID="15802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301756</ID>
                <ID Source="BookShelf">NBK5201</ID>
              </Citation>
              <XRef ID="90348" DB="Orphanet" />
              <XRef ID="C3280794" DB="MedGen" />
              <XRef ID="MONDO:0013751" DB="MONDO" />
              <XRef Type="MIM" ID="614434" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25992" SubmissionDate="2019-09-26" DateLastUpdated="2019-09-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604580.0002_CUTIS LAXA, AUTOSOMAL DOMINANT 2 (1 patient)" title="FBLN5, 483-BP DUP_CUTIS LAXA, AUTOSOMAL DOMINANT 2 (1 patient)" />
        <ClinVarAccession Accession="SCV000025992" DateUpdated="2019-09-29" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Markova et al. (2003) analyzed the expression of the elastin gene and the fibulin genes 1 through 5 in fibroblasts from 5 patients with cutis laxa (ADCL2; 614434). One patient was found to express both normal (2.2 kb) and mutant (2.7 kb) fibulin-5 mRNA transcripts. The larger transcript contained an internal duplication of 483 nucleotides, which resulted in the synthesis and secretion of a mutant fibulin-5 protein with 4 additional tandem calcium-binding epidermal growth factor-like motifs. The mutation arose from a 22-kb tandem gene duplication, encompassing the sequence from intron 4 to exon 9. No fibulin-5 or elastin mutations were detected in the other 4 patients.</Attribute>
              <Citation>
                <ID Source="PubMed">12618961</ID>
              </Citation>
              <XRef DB="OMIM" ID="614434" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBLN5" />
          </GeneList>
          <Name>FBLN5, 483-BP DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">483-BP DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604580.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CUTIS LAXA, AUTOSOMAL DOMINANT 2 (1 patient)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2022-12-21">SCV000041161</Accession>
        <Description>This variant is no longer cited in the GeneReview and has been deleted.</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

